Technical Analysis for THRD - Third Harmonic Bio, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 3.92% | |
| Upper Bollinger Band Walk | Strength | 3.92% | |
| Calm After Storm | Range Contraction | 0.99% | |
| Upper Bollinger Band Walk | Strength | 0.99% | |
| Inside Day | Range Contraction | 0.99% | |
| Upper Bollinger Band Touch | Strength | 0.99% | |
| 20 DMA Support | Bullish | -1.71% | |
| Pocket Pivot | Bullish Swing Setup | -1.71% | |
| Volume Surge | Other | -1.71% | |
| Wide Range Bar | Range Expansion | -1.71% |
| Alert | Time |
|---|---|
| Upper Bollinger Band Resistance | about 18 hours ago |
| Rose Above Upper Bollinger Band | about 19 hours ago |
| 60 Minute Opening Range Breakout | about 19 hours ago |
| Rose Above Previous Day's High | about 19 hours ago |
| Up 5% | about 19 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Allergy Type I Hypersensitivity Immunoglobulin E Mast Cell Chronic Urticaria
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Allergy Type I Hypersensitivity Immunoglobulin E Mast Cell Chronic Urticaria
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 16.94 |
| 52 Week Low | 5.765 |
| Average Volume | 203,525 |
| 200-Day Moving Average | 11.76 |
| 50-Day Moving Average | 13.05 |
| 20-Day Moving Average | 13.24 |
| 10-Day Moving Average | 13.72 |
| Average True Range | 0.90 |
| RSI (14) | 59.84 |
| ADX | 18.37 |
| +DI | 21.26 |
| -DI | 10.32 |
| Chandelier Exit (Long, 3 ATRs) | 12.29 |
| Chandelier Exit (Short, 3 ATRs) | 14.36 |
| Upper Bollinger Bands | 14.69 |
| Lower Bollinger Band | 11.79 |
| Percent B (%b) | 0.88 |
| BandWidth | 21.96 |
| MACD Line | 0.34 |
| MACD Signal Line | 0.22 |
| MACD Histogram | 0.1173 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 15.49 | ||||
| Resistance 3 (R3) | 15.47 | 15.05 | 15.30 | ||
| Resistance 2 (R2) | 15.05 | 14.75 | 15.06 | 15.23 | |
| Resistance 1 (R1) | 14.69 | 14.57 | 14.87 | 14.72 | 15.17 |
| Pivot Point | 14.28 | 14.28 | 14.37 | 14.29 | 14.28 |
| Support 1 (S1) | 13.92 | 13.98 | 14.10 | 13.94 | 13.49 |
| Support 2 (S2) | 13.50 | 13.80 | 13.51 | 13.43 | |
| Support 3 (S3) | 13.14 | 13.50 | 13.36 | ||
| Support 4 (S4) | 13.17 |
